Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
New criminal sanctions for those who fail to protect children from sexual exploitation are at the heart of new measures to be introduced.
Student Charlie Mann was jailed for 16 months for the attack on his mother at their family home while high on Meow Meow.
Monday night's weather for the east of the region